EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Streamlined Self-Collection Screening for Sexually Transmitted Infections and Human Papillomavirus

Anisha P Ganguly, Peyton K Pretsch, Noel T Brewer, Lisa P Spees, Michael G Hudgens, Busola Sanusi, Lynn Barclay, Alicia Carter, Stephanie B Wheeler, Jennifer S Smith

JAMA Network Open · 2026

DOI: 10.1001/jamanetworkopen.2025.51345 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, 2026. Verfasst von Anisha P Ganguly und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, School of Medicine, University of North Carolina at Chapel Hill. Hauptthemen laut MEDLINE: Papillomavirus Infections, Sexually Transmitted Diseases, Early Detection of Cancer, Uterine Cervical Neoplasms. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Human papillomavirus (HPV) self-collection increases cervical cancer screening uptake among women underscreened for cervical cancer, particularly those from marginalized low-income and racial and ethnic backgrounds. Underscreened women are also at high risk for other sexually transmitted infections (STIs) that can be similarly screened via self-collection.

Objective

To evaluate an intervention streamlining testing for other STIs alongside HPV self-collected samples among low-income women. Design, Setting, and Participants This is a secondary analysis of the My Body, My Test–3 study, a randomized clinical trial testing a mailed self-collection intervention to improve cervical cancer screening. The My Body, My Test–3 study was conducted from April 2016 to December 2019 in 22 counties in North Carolina among low-income women overdue for cervical cancer screening. This analysis included participants randomized to the trial intervention group with valid STI and HPV results. Data analysis occurred from October 2024 to February 2025.

Intervention

The intervention included a mailed self-collection kit and instructions to self-collect a cervicovaginal sample. Samples were tested for other STIs and HPV using the Aptima assay. Main Outcomes and Measures The primary outcome was a positive test result for other STIs (including chlamydia, gonorrhea, and trichomoniasis). A risk factor analysis was conducted to identify factors associated with testing positive for other STIs. Secondary outcomes included rate of follow-up care and perceptions of self-collection among participants with positive STI results.

Results

Among 327 participants (median [IQR] age, 42 [25-63] years; 38 [8.6%] Hispanic, 146 [44.7%] non-Hispanic Black, and 133 [40.7%] non-Hispanic White), 51 (15.6%) tested positive for other STIs and 51 (15.6%) tested positive for HPV; 7 (2.1%) tested positive for both. Risk factors for other STIs included non-Hispanic Black race and ethnicity compared with non-Hispanic White race and ethnicity (adjusted odds ratio [aOR], 4.1; 95% CI, 1.5-11.6), having 2 or more sexual partners in the last year compared with having none (aOR, 5.7; 95% CI, 1.0-31.4), single marital status compared with married or partnered status (aOR, 5.6; 95% CI, 1.1-27.9), and current smoking compared with none (aOR, 4.1; 95% CI, 1.7-10.4). Among participants who tested positive for other STIs, 34 (66.7%) received follow-up care. Most participants (130 [84.4%]) preferred testing for both HPV and other STIs in the future. Conclusions and Relevance In this secondary analysis of a randomized clinical trial of 327 participants, nearly 1 in 6 tested positive for other STIs via streamlined testing in a mailed HPV self-collection intervention. Self-collection may improve both cervical cancer and STI screening for women from marginalized backgrounds. Trial Registration ClinicalTrials.gov Identifier: NCT02651883

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsSexually Transmitted DiseasesEarly Detection of CancerUterine Cervical NeoplasmsSpecimen HandlingMass ScreeningSelf CareHumansFemaleAdultMiddle AgedNorth CarolinaVaginal SmearsHuman Papillomavirus Viruses

Autor:innen und Institutionen

  • Department of Internal Medicine, School of Medicine, University of North Carolina at Chapel Hill.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill.
  • Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill.
  • Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill.
  • Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill.
  • Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill.

Zitieren

APA

Ganguly, A. P., Pretsch, P. K., Brewer, N. T., Spees, L. P., Hudgens, M. G., Sanusi, B., Barclay, L., Carter, A., Wheeler, S. B., & Smith, J. S. (2026). Streamlined Self-Collection Screening for Sexually Transmitted Infections and Human Papillomavirus. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.51345

Vancouver

Ganguly AP, Pretsch PK, Brewer NT, Spees LP, Hudgens MG, Sanusi B, et al. Streamlined Self-Collection Screening for Sexually Transmitted Infections and Human Papillomavirus. JAMA Network Open. 2026. doi:10.1001/jamanetworkopen.2025.51345

BibTeX
@article{Ganguly2026,
  author = {Ganguly, Anisha P and Pretsch, Peyton K and Brewer, Noel T and Spees, Lisa P and Hudgens, Michael G and Sanusi, Busola and Barclay, Lynn and Carter, Alicia and Wheeler, Stephanie B and Smith, Jennifer S},
  title = {Streamlined Self-Collection Screening for Sexually Transmitted Infections and Human Papillomavirus},
  journal = {JAMA Network Open},
  year = {2026},
  doi = {10.1001/jamanetworkopen.2025.51345}
}
Kostenlos starten →